DTA is delighted to announce DTxCC (Digital Therapeutics Commercialization Consultants, LLC) as our newest Resource Partner. Through this relationship, DTxCC will support members by sharing their deep expertise in market access, reimbursement, and monetization strategies as well as providing actionable insights on best practices for approaching payors to generate optimal commercialization strategies.
As reimbursement challenges remain one of the biggest challenges in scaling access to #digitaltherapeutics, tapping into DTxCC's expertise in engaging payors will help our members strengthen their business planning in this area.
Our Resource Partner Program is bringing together expertise and resources from across the industry to build a best-in-class network of commercialization and product development service providers. This program supports our members' work to accelerate the development and post-launch success of digital therapeutics to improve healthcare.
DTA’s Resource Partner Program is accelerating the development and post-launch success of clinically evaluated digital therapeutics by building a best-in-class network of commercialization and product development service providers.
DTA members receive insights and guidance with access to experts as well as curated education and resources. Our Resource Partners support our work to broaden the understanding, adoption, and integration of clinically evaluated digital therapeutics into healthcare by sharing their expertise with members and through the development of resources outlining best practices.
Through their relationship with DTA, Resource Partners are recognized as leading experts in the rapidly advancing market of digital therapeutics and interact directly with members in Work Groups, collaborative industry leading projects, engaging in our DTx Slack community, and by participating in Town Hall events. You can read more here.